Abstract: The application pertains to methods of treating and/or preventing actinic keratosis, comprising administering a therapeutically effective amount of KX-01, to a subject in need thereof.
Type:
Grant
Filed:
February 28, 2020
Date of Patent:
November 15, 2022
Assignee:
ATNX SPV, LLC
Inventors:
Min-Fun Rudolf Kwan, Johnson Yiu-Nam Lau, E. Douglas Kramer, David Lawrence Cutler, Jane Fang